Exploring the expression of cancer stem cell marker – Aldehyde dehydrogenase isoenzyme 1A1 (ALDH1A1) in various molecular subtypes of breast cancer | Synapse
March 3, 2026
Exploring the expression of cancer stem cell marker – Aldehyde dehydrogenase isoenzyme 1A1 (ALDH1A1) in various molecular subtypes of breast cancer
Key Points
ALDH1A1 expression varies significantly among different molecular subtypes of breast cancer, indicating its role in cancer stem cells.
The study highlights that ALDH1A1 may serve as a potential biomarker for identifying aggressive breast cancer characteristics.
Assessment revealed that higher levels of ALDH1A1 correlate with certain aggressive breast cancer subtypes, possibly informing treatment decisions.
Findings support the need for further exploration of ALDH1A1 as a therapeutic target in breast cancer management.